The gravity of the threat posed by vivax malaria to public health has been poorly appreciated. The widely held misperception of Plasmodium vivax as being relatively infrequent, benign, and easily treated explains its nearly complete neglect across the range of biological and clinical research. Recent evidence suggests a far higher and more-severe disease burden imposed by increasingly drug-resistant parasites. The two frontline therapies against vivax malaria, chloroquine and primaquine, may ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Resistance to therapies for infection by Plasmodium vivax.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record